Logo image
Respiratory dysfunctions induced by prenatal nicotine exposure
Journal article   Open access   Peer reviewed

Respiratory dysfunctions induced by prenatal nicotine exposure

Marlys Campos, Eduardo Bravo and Jaime Eugenin
Clinical and experimental pharmacology & physiology, Vol.36(12), pp.1205-1217
12/01/2009
DOI: 10.1111/j.1440-1681.2009.05214.x
PMID: 19473189
url
http://americanae.aecid.es/americanae/es/registros/registro.do?tipoRegistro=MTD&idBib=3270841View
Open Access

Abstract

P>Maternal tobacco smoking is the principal risk factor associated with sudden infant death syndrome (SIDS), a leading cause of death of infants under 1 year of age. Victims of SIDS show a higher incidence of respiratory control abnormalities, including central apnoeas, delayed arousal responses and diminished ventilatory chemoreflexes. Nicotine is likely the link between maternal tobacco smoking and SIDS. Prenatal nicotine exposure can alter the breathing pattern and can reduce hypoxia- and hypercarbia-induced ventilatory chemoreflexes. In vitro approaches have revealed that prenatal nicotine exposure impairs central chemosensitivity, switching the cholinergic contribution from a muscarinic to a nicotinic receptor-based drive. In addition, serotonergic, noradrenergic, GABAergic, glycinergic and glutamatergic, among others, are affected by prenatal nicotine. Here we propose that prenatal nicotine affects the respiratory network through two main processes: (i) reorganization of neurotransmitter systems; and (ii) remodelling of neural circuits. These changes make breathing more vulnerable to fail in early postnatal life, which could be related to the pathogenesis of SIDS.
Life Sciences & Biomedicine Pharmacology & Pharmacy Physiology Science & Technology

Details

Metrics

Logo image